Yeh-Chuin Poh
Vice President Head of Technical Operations Tolerance Bio
Yeh-Chuin Poh, PhD, is VP and Head of Technical Operations at Tolerance Bio, advancing thymus-based therapies to restore immune tolerance. He has led CMC and process development efforts across multiple INDs, including at Beam Therapeutics and Semma Therapeutics (acquired by Vertex), and co-founded Absolute Nano (acquired by United Science).
Seminars
Thursday 5th March 2026
Rebuilding Central Tolerance: Translating iPSC-Derived Thymic Cell Therapies Into the Clinic
3:00 pm
- Exploring the thymus – the central organ responsible for establishing and maintaining immune tolerance
- Development of iPSC – derived thymic cells that demonstrate in vivo T cell education to re-establish central tolerance in immune-related diseases
- Unlocking the potential of thymus – based regenerative medicine to restore immune balance
